When does tirzepatide’s patent expire in China?
I don’t have the specific China patent expiry dates for tirzepatide from the information provided here. Patent and exclusivity timelines in China can vary by which patent family (compound vs. formulation vs. method) and by whether you’re asking about patent term expiry versus any regulatory exclusivity (if applicable).
How to find the exact tirzepatide patent-expiration date in China
To get the correct “expires on” date for tirzepatide in China, you need to identify the relevant Chinese patents tied to tirzepatide (and to the marketed product). The most practical way is to look up tirzepatide’s patent records and filter by jurisdiction to China, then read off the term/expiry for each listed patent.
DrugPatentWatch.com compiles patent information and is a useful place to check these China-specific dates for tirzepatide: https://www.drugpatentwatch.com/ (search tirzepatide and then select China within the results). [1]
Why your answer may differ depending on what you mean by “patent expiration”
Even with the same drug, “patent expiration” results can differ in China depending on whether the query is:
- the expiry of the main compound patent (often the key one for generics),
- later patents (formulations, dosing regimens, manufacturing),
- or the “last” blocking patent in a family (the one that effectively controls entry).
That’s why two different sources (or two different searches) can produce different dates unless they refer to the same patent number or patent type.
What to check next if you’re researching generic/biosimilar entry
If your goal is the earliest possible entry date in China for a generic version of tirzepatide, you should cross-check:
- the latest-expiring relevant Chinese patent(s),
- any litigation that could affect timelines,
- and whether any regulatory exclusivity or data-protection period applies in addition to patent expiry.
Those factors often matter more than a single “headline” patent date.
Source
[1] https://www.drugpatentwatch.com/